The United States continues to lead the Adenomyosis Treatment Market due to the rising prevalence of adenomyosis among women of reproductive age and those nearing menopause. Increasing awareness of women's reproductive health, widespread access to advanced diagnostic technologies such as MRI and transvaginal ultrasound, and strong healthcare infrastructure have significantly improved...